Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Rubin Lab
Explore this Website
Home
News
About Us
Research
Lab Team
Publications
Resources
Toggle Resources menu options
FISH
Profiler
Tracking Samples
Weill Cornell Medicine
Care
Discover
Teach
Home
News
About Us
Research
Lab Team
Publications
Resources
Home
Publications
Publications
Found 115 results
Author
Title
Type
Year
2006
Hofer MD
,
Kuefer R
,
Huang W
,
Li H
,
Bismar TA
,
Perner S
,
Hautmann RE
,
Sanda MG
,
Gschwend JE
,
Rubin MA
. 2006.
Prognostic factors in lymph node-positive prostate cancer.
.
Urology. 67(5):1016-21.
Perner S
,
Demichelis F
,
Beroukhim R
,
Schmidt FH
,
Mosquera J-M
,
Setlur S
,
Tchinda J
,
Tomlins SA
,
Hofer MD
,
Pienta KG
et al.
. 2006.
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.
.
Cancer Res. 66(17):8337-41.
2007
Mertz KD
,
Demichelis F
,
Kim R
,
Schraml P
,
Storz M
,
Diener P-A
,
Moch H
,
Rubin MA
. 2007.
Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer.
.
Hum Pathol. 38(10):1454-62.
Setlur SR
,
Royce TE
,
Sboner A
,
Mosquera J-M
,
Demichelis F
,
Hofer MD
,
Mertz KD
,
Gerstein M
,
Rubin MA
. 2007.
Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer.
.
Cancer Res. 67(21):10296-303.
Mertz KD
,
Setlur SR
,
Dhanasekaran SM
,
Demichelis F
,
Perner S
,
Tomlins S
,
Tchinda J
,
Laxman B
,
Vessella RL
,
Beroukhim R
et al.
. 2007.
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.
.
Neoplasia. 9(3):200-6.
Mosquera J-M
,
Perner S
,
Demichelis F
,
Kim R
,
Hofer MD
,
Mertz KD
,
Paris PL
,
Simko J
,
Collins C
,
Bismar TA
et al.
. 2007.
Morphological features of TMPRSS2-ERG gene fusion prostate cancer.
.
J Pathol. 212(1):91-101.
Cohen RJ
,
Wheeler TM
,
Bonkhoff H
,
Rubin MA
. 2007.
A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma.
.
Arch Pathol Lab Med. 131(7):1103-9.
Perner S
,
Hofer MD
,
Kim R
,
Shah RB
,
Li H
,
Möller P
,
Hautmann RE
,
Gschwend JE
,
Kuefer R
,
Rubin MA
. 2007.
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression.
.
Hum Pathol. 38(5):696-701.
Barry M
,
Perner S
,
Demichelis F
,
Rubin MA
. 2007.
TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications.
.
Urology. 70(4):630-3.
Perner S
,
Mosquera J-M
,
Demichelis F
,
Hofer MD
,
Paris PL
,
Simko J
,
Collins C
,
Bismar TA
,
Chinnaiyan AM
,
De Marzo AM
et al.
. 2007.
TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion.
.
Am J Surg Pathol. 31(6):882-8.
Demichelis F
,
Fall K
,
Perner S
,
Andrén O
,
Schmidt F
,
Setlur SR
,
Hoshida Y
,
Mosquera J-M
,
Pawitan Y
,
Lee C
et al.
. 2007.
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.
.
Oncogene. 26(31):4596-9.
Demichelis F
,
Rubin MA
. 2007.
TMPRSS2-ETS fusion prostate cancer: biological and clinical implications.
.
J Clin Pathol. 60(11):1185-6.
2008
Mertz KD
,
Demichelis F
,
Sboner A
,
Hirsch MS
,
Dal Cin P
,
Struckmann K
,
Storz M
,
Scherrer S
,
Schmid DM
,
Strebel RT
et al.
. 2008.
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer.
.
Int J Cancer. 123(3):569-76.
Mosquera J-M
,
Perner S
,
Genega EM
,
Sanda M
,
Hofer MD
,
Mertz KD
,
Paris PL
,
Simko J
,
Bismar TA
,
Ayala G
et al.
. 2008.
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.
.
Clin Cancer Res. 14(11):3380-5.
Kelly KA
,
Setlur SR
,
Ross R
,
Anbazhagan R
,
Waterman P
,
Rubin MA
,
Weissleder R
. 2008.
Detection of early prostate cancer using a hepsin-targeted imaging agent.
.
Cancer Res. 68(7):2286-91.
Perner S
,
Wagner PL
,
Demichelis F
,
Mehra R
,
Lafargue CJ
,
Moss BJ
,
Arbogast S
,
Soltermann A
,
Weder W
,
Giordano TJ
et al.
. 2008.
EML4-ALK fusion lung cancer: a rare acquired event.
.
Neoplasia. 10(3):298-302.
Setlur SR
,
Mertz KD
,
Hoshida Y
,
Demichelis F
,
Lupien M
,
Perner S
,
Sboner A
,
Pawitan Y
,
Andrén O
,
Johnson LA
et al.
. 2008.
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.
.
J Natl Cancer Inst. 100(11):815-25.
Demichelis F
,
Greulich H
,
Macoska JA
,
Beroukhim R
,
Sellers WR
,
Garraway L
,
Rubin MA
. 2008.
SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines.
.
Nucleic Acids Res. 36(7):2446-56.
Rubin MA
. 2008.
Targeted therapy of cancer: new roles for pathologists--prostate cancer.
.
Mod Pathol. 21 Suppl 2:S44-55.
2009
Demichelis F
,
Setlur SR
,
Beroukhim R
,
Perner S
,
Korbel JO
,
Lafargue CJ
,
Pflueger D
,
Pina C
,
Hofer MD
,
Sboner A
et al.
. 2009.
Distinct genomic aberrations associated with ERG rearranged prostate cancer.
.
Genes Chromosomes Cancer. 48(4):366-80.
Tomlins SA
,
Bjartell A
,
Chinnaiyan AM
,
Jenster G
,
Nam RK
,
Rubin MA
,
Schalken JA
. 2009.
ETS gene fusions in prostate cancer: from discovery to daily clinical practice.
.
Eur Urol. 56(2):275-86.
Hofer MD
,
Kuefer R
,
Maier C
,
Herkommer K
,
Perner S
,
Demichelis F
,
Paiss T
,
Vogel W
,
Rubin MA
,
Hoegel J
. 2009.
Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.
.
Cancer Res. 69(2):640-6.
Stark JR
,
Perner S
,
Stampfer MJ
,
Sinnott JA
,
Finn S
,
Eisenstein AS
,
Ma J
,
Fiorentino M
,
Kurth T
,
Loda M
et al.
. 2009.
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?
J Clin Oncol. 27(21):3459-64.
Pflueger D
,
Rickman DS
,
Sboner A
,
Perner S
,
Lafargue CJ
,
Svensson MA
,
Moss BJ
,
Kitabayashi N
,
Pan Y
,
de la Taille A
et al.
. 2009.
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer.
.
Neoplasia. 11(8):804-11.
Mosquera J-M
,
Mehra R
,
Regan MM
,
Perner S
,
Genega EM
,
Bueti G
,
Shah RB
,
Gaston S
,
Tomlins SA
,
Wei JT
et al.
. 2009.
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.
.
Clin Cancer Res. 15(14):4706-11.
« first
‹ previous
1
2
(current)
3
4
5
next ›
last »